MARKET REPORT: Indivior shares dive as it axes schizophrenia drug
![MARKET REPORT: Indivior shares dive as it axes schizophrenia drug](https://i.dailymail.co.uk/1s/2024/07/09/21/87130713-0-image-m-3_1720556715175.jpg)
The London-listed pharma company will stop sales of its Perseris medicine because it said the monthly injection is 'no longer financially viable'.
The London-listed pharma company will stop sales of its Perseris medicine because it said the monthly injection is 'no longer financially viable'.